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Biological monitoring of exposure to chemicals in the workplace is an important component of
exposure assessment and prevention of adverse health effects. It should be employed in
conjunction with ambient air monitoring to provide information on the absorbed dose of a
chemical agent and the effect of all routes of exposure. Judgments regarding the acceptable level
of a chemical or its metabolite in biological samples are facilitated by comparison to a reference
value. The American Conference of Governmental Industrial Hygienists has established a series
of recommended reference values called the Biological Exposure Indices (BEI). The history and
characteristics of the BEI are reviewed, and their suitability for use by occupational health
specialists is examined. A number of challenges and stimuli to the continued development and
improvement of these reference values are described, and the impact of recent advances in
macromolecular biology is assessed. Environ Health Perspect 105(Suppl 1):105-115 (1997)
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Introduction
Biological monitoring is generally described
as the planned and repeated collection of
specimens of tissue or body fluid, for the
purpose ofestimating the chemical compo-
sition of the body's internal environment.
The repeated aspect differentiates monitor-
ing from sampling and emphasizes the
point that temporal changes in chemical
composition are just as important as the
estimates at a single time.
Motivations for biological monitoring
arise in clinical medicine, forensic toxicol-
ogy, and occupational hygiene. Medical
applications include the repeated sampling
ofperipheral blood to assess the circulating
level ofa therapeutic drug given as a means
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oftreating a diagnosed illness. The biologi-
cal monitoring data provide the informa-
tion necessary to adjust the dosing regimen
to account for the individual characteristics
of the patient and to achieve the desired
effect without overexposure. The major
application of biological monitoring in
forensic toxicology is the periodic sampling
ofvoided urine ofworkers in certain criti-
cal jobs, followed by analysis for evidence
of use of incapacitating or illegal drugs or
other substances. It should be noted that
the collection ofa breath sample by a traf-
fic officer who suspects a driver ofethanol
intoxication would fit the description of
biological sampling but not monitoring. In
occupational hygiene, biological monitor-
ing is used as part ofan array oftechniques
for evaluating the worker's risk ofhealth
damage due to exposure to chemical agents
and it is especially valuable when con-
ducted to indicate exposure to a potentially
harmful chemical at a time when preven-
tive measures can be effective in reducing
or eliminating the health risk.
Occupational biological monitoring
must be viewed as complementary to, and
not a replacement for, the more traditional
measurement ofairborne concentrations of
chemical agents (1). It provides additional
information that can be of great value in
evaluating and controlling risky exposures.
The advantages offered by biological
monitoring in the occupational setting
have been thoroughly reviewed by others
(2-4) and will not be explored here in any
detail. This form of exposure monitoring
invokes some additional requirements,
however, one ofwhich is the existence of
reference values against which observed
biological concentrations may be compared
to form judgments about the acceptability
ofthe workplace conditions.
One substantial collection of reference
values for biological monitoring in work-
places is the list of Biological Exposure
Indices (BEI) published by the American
Conference of Governmental Industrial
Hygienists (ACGIH). Organizations such
as the ACGIH, together with governmen-
tal regulating agencies, perform a key role
at the interface between science and policy;
ideally, their mission is to use the best
available scientific and technical data to set
recommended or regulatory limits that will
minimize the health risks to workers while
maximizing the benefit to society of the
economic activity associated with the work.
This review describes the BEI in terms
ofthe philosophy and process under which
they are established and the role they play
in the practice ofoccupational hygiene and
occupational medicine. The extent to which
the BEI meet the expectations ofthe scien-
tific, regulatory, and practitioner commu-
nities will be addressed and their strengths
and limitations will be explored. The pace
ofscientific development offers the oppor-
tunity to speculate on directions to be taken
in generating or revising the BEI and other
reference values for biological monitoring
over the next decade.
Defining Characteristics
ofthe Biological
Exposure Indices
The BEI are reference values intended as
guidelines for the evaluation ofpotential
health hazards in the practice of industrial
hygiene (5). The mission of industrial
hygiene is the anticipation, recognition,
evaluation, and control of exposure to
health hazards in the workplace, with the
overall aim of preventing or minimizing
adverse health effects of exposure. Thus,
when the BEI are used by physicians,
nurses, engineers, or industrial hygienists,
their principal application should be to
support prevention ofinjurious exposures.
These reference values are the recom-
mendations of a professional society, the
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ACGIH, which also establishes reference
values for airborne chemical concentrations
in the workplace. The latter are called
Threshold Limit Values (TLV) and repre-
sent conditions under which nearly all
workers may be exposed repeatedly over a
working lifetime without adverse health
effects. It should be noted that theACGIH
is a private organization without regulatory
authority and its reference values are
offered as recommendations for good prac-
tice without guarantee that they are a clear
demarcation between safe and unsafe
conditions. As presented by the ACGIH,
industry compliance with the BEI and the
TLV is voluntary. Despite this disclaimer,
the TLV and to a lesser extent the BEI
have been used by government agencies
around the world as the basis forworkplace
environmental regulations.
The BEI are developed by the BEI
Committee ofthe ACGIH, which consists
ofvolunteer scientists and practicing pro-
fessionals with expertise in occupational
medicine, toxicology, industrial hygiene,
analytical chemistry, biostatistics, and epi-
demiology. The present committee mem-
bers include specialists from the United
States, Japan, Germany, Switzerland, and
the United Kingdom employed in acade-
mia, government, or private industry (the
last category of members does not have
voting privileges but otherwise participates
fully in the process.) The committee meets
twice a year to develop new reference values
and to conduct a regular review ofexisting
BEI as new data emerge. Several values
have undergone significant revision as a
result of such review; examples will be
described below.
The BEI are intended for use in bio-
logical monitoring where the goal is the
determination of the worker's internal, or
biologically effective, dose of a chemical.
The determinant may be the parent com-
pound itself, metabolite(s), or a characteris-
tic reversible biochemical change induced
upon absorption. The index values repre-
sent the level of the determinant most
likely to be observed in specimens collected
from a worker with an internal dose equiv-
alent to that arising solely from inhalation
exposure at the TLV concentration (5).
Thus, most ofthe BEI are closely linked to
the corresponding TLV and are based on
preventing the same health effect addressed
by the TLV. This does not imply, however,
that airborne concentrations and biological
levels must always be correlated in exposed
workers, since routes of absorption in
addition to inhalation are possible. Where
this occurs, comparison ofbiological levels
to the BEI takes on special importance,
since the BEI represents the acceptable
internal exposure regardless ofthe route(s)
ofentry.
History ofthe Development
of Biological Exposure Indices
Biological monitoring has been used as one
ofseveral complementary tools for assess-
ing worker exposure to chemicals for at
least 60 years (6)-more widely in Europe
than in the United States (7). The present
general concept of biological monitoring
reference values used by the ACGIH can
be attributed to the work ofElkins (8,9)
beginning in 1954. He noted that knowl-
edge of metabolism and excretion ofeach
specific chemical was necessary to interpret
results properly and he presented a series of
recommended biological exposure limit
values for solvents.
American Conferenceof
GovernmentalIndustrialHygienist'
Threshold LimitValues Committee
The ACGIH recognized the value of the
concept of biological monitoring in the
early 1970s, and in 1973 first included a
discussion ofbiological limit values in its
annual listing ofTLV (10), although no
values were adopted at that time. During
the subsequent decade there was consider-
able debate over theACGIH role in biolog-
ical monitoring and medical surveillance.
The debate ended in 1982 with a resolu-
tion that the organization should become
active in biological monitoring in parallel
with developing TLV, but should not have
a direct role in medical surveillance.
ACGIH viewed biological monitoring as a
measure of absorption, metabolism, or
excretion ofan industrial chemical and not
as a measure of toxicity or health effect,
thus attempting to distinguish it from
medical surveillance (11).
Creation oftheBiological EFxposure
Indices Committee
In 1982, ACGIH Board of Directors
appointed a new committee to develop
reference values for biological monitoring
based on the above philosophy. The charge
to the committee was to review current
scientific literature and recommend BEI
that can be sufficiently documented. In
addition, tentative BEI were to be sug-
gested for chemicals for which useful but
insufficient data or methods were avail-
able, as encouragement for generation of
additional data.
The BEI Committee was organized in
1983 and included five members plus two
consultants from private industry. The
group developed awritten description ofthe
definition and interpretation ofthe refer-
ence values, together with six recommended
values in 1984: the substances covered were
carbon monoxide, ethyl benzene, styrene,
toluene, trichloroethylene, and the xylene
isomers. In accord with the procedures for
the TLV, these recommendations were pro-
posed to the ACGIH membership using a
formal mechanism for eliciting comment
(see procedure section) and adopted as the
first Biological Exposure Indices in 1986.
In subsequent years, BEI have been devel-
oped for 29 additional chemicals or groups
ofchemicals, and 7 existing BEI have been
revised in response to appearance of new
data in the scientific literature.
Present Status: Procedure
for Establishing Biological
Exposure Indices
Establishing a BEI has evolved since the
early days of the BEI Committee into a
staged process consisting of a) feasibility
analysis, b) development of a proposed
BEI, c) formal publication ofthat proposal
with an invitation for comment from all
parties, d) review and possible revision of
the proposal, and e) final adoption by the
voting members ofACGIH. At each stage,
the actions of the BEI Committee are
subject to review by members of the
ACGIH Board of Directors, who are
elected in turn by the membership.
One of the critical decisions in the
process is the initial one regarding the fea-
sibility ofestablishing a new BEI. In the
course ofmaking this decision, the com-
mittee considers several criteria discussed
in a written feasibility assessment prepared
by one or two committee members. The
criteria are listed below.
ExtentofSystemicAbsorption
andDisposition
Substances must be absorbed into the
circulation to the extent that target tissues
remote from the site ofentry are affected
and so that accessible biological fluids
or tissues contain the chemical or its
metabolite in detectable concentration.
An industrial chemical with potent toxic
properties that exerts its effect only topi-
cally or only at the site of absorption is
not a candidate for setting a BEI, since
biological monitoring is unlikely to gener-
ate information useful for preventing or
minimizing exposure.
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SizeoftheExosedWorkerPopulation
Although there is no specific quantitative
requirement for this aspect, data on the size
of the population are needed. In general,
exposures to workers should occur in more
than a single industrial facility and prefer-
ably in the workplaces of more than one
company. Equally important is the recent
trend in these data, as asubstance whose use
in industry is decreasing may be ofmuch
less interest than one whose production and
use are growing. The influence ofthis factor
maybe diminished for a substance withvery
potent toxicity for which other feasibility
criteria are particularly compelling, such as
the glycol ethers, which may penetrate the
skin in significant amounts.
Existence ofaThesholdLimit
ValuefortheSubstance
The great majority of BEI are directly
related to the corresponding TLV. They
address the same health outcome and repre-
sent the expected internal dose correspond-
ing to inhalation at the TLV. Exceptions to
this criterion have been made in the past
and establish a precedent for similar future
exceptions where the other feasibility criteria
argue strongly for establishing a BEI. The
present exceptions are BEI for classes of
compounds inducing methemoglobinemia
andforthose inhibiting acetyl cholinesterase.
HumansToxicokinetic Data
AreAvailable
There should be sufficient data of high
quality that describe the absorption, sys-
temic distribution, metabolism, storage,
and excretion of the compound or its
metabolites. These are necessary to support
the selection ofthe appropriate analyte, the
tissue or fluid to be sampled, and the tim-
ing ofthe sample. The committee requires
that the toxicokinetic studies be published
in the peer-reviewed scientific literature so
their quality can be assessed by all inter-
ested parties. In some instances, validated
toxicokinetic models have been used where
experimental human data were not suffi-
cient. Further, toxicodynamic data may also
be appropriate in instances where the
anticipated BEI would be directly related
to health effect rather than to an airborne
concentration. This particular means of
developing a BEI has been used only rarely
to date.
Analytical Chemical Methods
AreAvailable
Data in the peer-reviewed literature must
demonstrate that a method exists for assay
ofthe determinant with acceptable accu-
racy, precision, and sensitivity. These per-
formance characteristics must perniit
analysis ofthe determinant in the recom-
mended tissue or fluid sampled at levels
both below and above the anticipated level
ofthe BEI. Inadequate analytical method-
ology will preclude the development ofa
reference value.
An affirmative feasibility decision
launches the development of a proposed
BEI by one or two members of the com-
mittee. The written proposal will include
the identity of the industrial chemical or
category ofsubstances addressed together
with its CAS number and chemical for-
mula. The recommended BEI includes the
identity ofall determinants-parent com-
pound, metabolite(s), biochemical change-
together with the medium to be samplcd,
the time ofcollection relative to the expo-
sure period, and the numerical value ofthe
index expressed as a concentration or per-
centage ofnormal. In many instances there
will also be a notation that marks one or
more special considerations for the BEI,
such as the need to account for background
levels in workers due to exposure outside
the workplace. An example the contents of
the BEI is shown in Table 1.
A proposed BEI is supported by a doc-
ument that reviews the scientific data used
in developing the reference value and that
contains a synoptic rationale for the recom-
mendation. The documentation must con-
form to a standard format incorporating
relevant physical and chemical properties
ofthe chemical; toxicokinetic data; discus-
sion ofpossible nonoccupational exposure;
the value and rationale for the correspond-
ing TLV; a discussion of sampling and
analytical methods for the determinant(s);
anticipated biological levels without occu-
pational exposure; the timing of appear-
ance ofthe determinant; factors affecting
interpretation ofthe measurement; thejusti-
fication for the recommended BEI together
with a critical assessment of the current
data available; and finally, a description of
Table 1. Example ofthe contents of each Biological ExposL
reference values recommended or required
by other organizations. All literature used
in the preparation ofthe documentation is
cited and a copy of each item must be
provided for archiving.
The BEI Committee then conducts a
thorough review ofthe proposed BEI and its
documentation. A member not involved in
the preparation ofthe proposal is assigned
to lead this review, during which special
attention is paid to the correspondence of
the BEI to the TLV if that approach has
been used, or to the relationship to health
effects data ifnot. Conformance to the fea-
sibility assessment is considered and the
practical aspects ofsampling, analysis, and
interpretation are examined. The review
process is one ofscientific judgment based
upon the weight ofavailable evidence and
does not include a quantitative risk assess-
ment. The approach in most cases has been
to select the level ofeach determinant that
is most likely to result from inhalation
exposure at the TLV. The decision takes
account oftypical workers' physical activi-
ties during exposure and pays particular
attention to experimental or epidemiologic
data on the toxicokinetics of the com-
pound. The final recommendation is
invariably a consensus ofthe voting mem-
bers of the committee. Revisions to the
documentation are often agreed upon at
this stage in response to comments from
the committee members.
BEI recommendations from the com-
mittee are then reviewed by the ACGIH
Board ofDirectors and, ifapproved, placed
on the agenda of the ACGIH Annual
Membership meeting for vote ofapproval
by the members. A favorable vote at this
point results in publication ofthe proposed
BEI in the "Notice of Intent to Establish
or Change." This appears in the booklet
(5) published annually by the ACGIH
containing the adopted and proposed values
for all TLV and BEI and is a formal invita-
tion for comment and criticism from all
interested parties. Annual circulation ofthe
booklet is over 100,000 copies worldwide.
Carbon monoxide
CAS: 630-08-0
CO
Recommended BEI determinant Sampling time BEI Notationa
Carboxyhemoglobin in blood End of shift 3.5% ofhemoglobin B, Ns
Carbon monoxide in end-exhaled air End ofshift 20 ppm B, Ns
Abbreviations: B, determinant is usually present at a significant level in subject not occupationally exposed; Ns,
determinant is nonspecific, since it is present after exposure to other chemicals. ABackground levels are included
in the BEI value.
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Documentation of the proposed BEI is
available from theACGIH by request.
The proposed BEI must remain on the
"Notice ofIntent to Establish or Change"
list for at least 1 year, after which the com-
mittee reviews all comments received as
well as any new scientific data to emerge.
Revisions may be made to the BEI and its
documentation, after which another con-
sensus is reached regarding adoption. If a
proposed BEI is revised at this point, the
new proposal must spend another year on
the Notice ofIntent list. After the required
notice period, a recommendation for adop-
tion is again reviewed by the Board of
Directors and the ACGIH membership.
Final adoption results in publication ofthe
BEI in the booklet as an established refer-
ence value and incorporation ofthe new
documentation into the three-volume set
published by theACGIH (12), which con-
tains all the documentation for the TLV
and BEI.
Asignificant aspect ofthe TLVand BEI
procedure is the periodic reexamination of
the adopted reference values. Generally the
original authors ofthe documentation are
expected to monitor the scientific literature
for new data that may bear on the BEI. A
proposal for revision may be presented at
any time and can be acted on within one
year ofpresentation. In this way the collec-
tion ofBEI can be kept consistent with cur-
rent science and thus will be of maximum
utility to occupational health practitioners.
The annual publication of the TLV/BEI
booklet reveals numerous revisions as a con-
sequence of this continued surveillance.
The frequent updating ofthe ACGIH ref-
erence values stands in marked contrast to
the much slower, legislatively mandated,
process of the U.S. Occupational Safety
and Health Administration in revising its
regulations governing the same substances.
Examples ofCurrentBiological
ExosureIndices
To shed further light on the decision-
making process used by the BEI commit-
tee, several examples of recently adopted
or revised BEI are described by summariz-
ing the justification and rationale for the
recommended reference values.
Lead. The BEI has been set at a level to
prevent or minimize effects that are
believed to result in persistent functional
impairment ofthe worker or his or her off-
spring. Certain effects may be seen at
blood lead levels below the BEI of 30
fig/dl. These are not believed to represent
significant impairment either because the
effect is reversible or transient and is not
likely to result in permanent impairment
or because the body's reserve capacity sus-
tains normal function despite aslight deficit
in enzyme activity. The recommended BEI
is intended to prevent or minimize:
* Psychological and psychomotor effects
that appear at blood lead levels above
301g/dl but that do not exceed the ref-
erence values ofthe test methods (13);
* Changes in nerve conduction velocity
and latency intervals, which also appear
at blood lead levels above 30 pig/dl but
have uncertain association with worker
impairment (14);
* Decrements in the hematological reserve
capacity reported in one study at blood
lead levels above 40 pig/dl (15);
* Renal impairment, as measured by cre-
atinine dearance and proteinuria, where
minor changes that did not constitute
functional impairment were reported at
blood lead levels below 30 pg/dl and
increased rates of proteinuria were
reported at blood lead levels of40 pg/dl
and above (16,17);
* The occurrence of spontaneous abor-
tions and effects on male fertility where
some but not all studies reported posi-
tive associations with blood lead when
the level was above 30 pg/dl (18,19);
* Decreased length ofgestation and birth
weight in offspring ofexposed women,
where study results are mixed and
methods used were not universally
accepted in the scientific community.
Expert reviews conclude that ifthere is
an association with blood lead, it occurs
at levels above 30 pg/dl (20).
Clinical effects on renal function, bone
marrow, and central nervous system are
associated with blood lead levels of 50
jig/dl andhigher (12).
The present lead BEI was adopted in
1995 and represents a departure from stan-
dard practice in that the reference value is
based directly on the epidemiologic rela-
tionship to health effects rather than on the
corresponding air concentration. The prior
lead BEI was developed in 1987 and was
linked to the contemporary TLV; with the
rapid growth ofepidemiologic data on lead
exposure and health in both the general
and working populations, the BEI commit-
tee was persuaded that a different approach
was defensible. This appears to be the first
instance in which the revised BEI is not
closely linked to the TLV and may serve
as a precedent, although few other sub-
stances ofhealth significance have been so
thoroughly studied byepidemiologists.
Toluene. The present BEI for toluene
(set in 1986) includes hippuric acid in
urine, toluene in venous blood, and toluene
in exhaled air. The hippuric acid reference
value has the most solid basis in experi-
mental and epidemiologic data and is set to
correspond to the contemporary TLV
(21). The test is not specific, as there are
dietary sources ofother chemical precur-
sors to hippuric acid, and therefore simul-
taneous measurement oftoluene in blood
is recommended as a confirming test.
Although toluene in blood or breath is a
specific indicator, toxicokinetic data indi-
cate that the timing ofsample collection
relative to the end ofexposure is so critical
that these tests are not suitable alone for
quantitative exposure assessment (2,22).
Recently the TLV for toluene was
halved based on newer data associating
exposure with effects on the central nervous
system. The BEI is now under active con-
sideration in response to this change, but
the hippuric acid index poses some practi-
cal difficulties. Exposures at the new TLV
would be anticipated to produce hippuric
acid levels in urine that are at or below the
background levels in persons without occu-
pational exposure, based on studies in pop-
ulations in western Europe and the United
States (23). However, data from popula-
tions in Asian nations reveal significantly
lower background hippuric acid levels,
probably reflecting different dietary pat-
terns (24,25). The use ofthe hippuric acid
index in western populations may require
very careful measurements ofbackground
and may not be feasible in some working
populations. In other parts of the world
this will not be an issue and the BEI can be
revised in direct relationship to the TLV.
Other specific markers oftoluene exposure
are being sought to address this problem.
2-Methoxyethanol and Its Acetate.
This is a recently proposed BEI presently
on the Notice of Intent list. During the
feasibility analysis for this set of com-
pounds, it was apparent that toxicokinetic
and toxicodynamic data are inadequate
to serve as a basis for a quantitative index
ofexposure. The decision to proceed was
based on the importance ofthese chemicals
in industry and their adverse effects on
reproduction (26) together with the avail-
ability of a suitable analytical method for
the metabolite (27). The committee is
therefore recommending monitoring
2-methoxyacetic acid in urine, collected
after the last shift ofthe workweek, as an
indicator of weekly exposure to either
parent compound. No quantitative index
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is established because ofinsufficient toxi-
cokinetic data. However, the compounds
are readily absorbed through the skin and
dermal contact may be the primary route
ofoccupational exposure (28). Because of
the concern over potential reproductive
effects from dermal exposure, skin contact
should be minimized or prevented and
metabolite monitoring offers a valuable
measure of the effectiveness of control
methods. Since the metabolite is not nor-
mally found in the urine ofworkers not
exposed to the parent compounds, its pres-
ence is evidence ofexposure by dermal and
inhalation routes (29).
In developing this rationale, the com-
mittee has also proposed a special notation,
Nq (nonquantitative), to highlight the cir-
cumstances under which a BEI is proposed
with no value for the determinant level.
Tentative criteria for assigning the Nq
notation are a) health risk information and
an analytical method are adequate; b) the
number ofworkers potentially exposed is
high and the quantity ofchemical used is
high; c) dermal absorption is a likely major
route of uptake; d) background levels
are low.
This pair ofglycol ethers meets all of
the criteria except thesecond; there is some
doubt that the number ofexposed workers
continues to behigh given the rapidchanges
in solvent use in the aircraft and other
industries. Presently, however, sufficient
justification remains for the proposed BEI
with the nonquantitative notation.
The present list ofadopted BEI is sum-
marized in Table 2. For full details on each
determinant, including the recommended
sampling times and guidance on interpre-
tation ofresults, the documentation (12)
should be consulted.
The Role of Biological
Exposure Indices in
Occupational Health
Bioindicators oflure,
Effect, andSuscepdbility
In establishing its reference values for
biological monitoring, it is clear that the
ACGIH has chosen to limit application of
reference values to the early stages in the
induction ofoccupational disease. Figure 1
is a schematic diagram ofthe interaction of
environmental chemical exposurewith host
factors in determining individual susceptibil-
ity to disease. The progression from environ-
mental exposure to clinical disease includes
toxicokinetic processes that influence the
internal dose-the concentration of the
Table2. Compilation ofcurrent Biological Exposure Indices, with dates ofadoption and revision.
First Last
Chemical agent Biological Exposure Index Reference value adopted revised
Acetone
Aniline
Arsenic and
soluble compounds
including arsine
Benzene
Cadmium and
inorganic compounds
Carbon disulfide
Carbon monoxide
Chlorobenzene
Chromium (VI)
Cobalt
N,N-Dimethylacetamide
N,N-Dimethylformamide
2-Ethoxyethanol and
2-ethoxyethyl acetate
Ethyl benzene
Fluorides
Furfural
nHexane
Lead
Mercury
Methanol
Methemoglobin inducers
Methyl chloroform
Methyl ethyl ketone
Methyl isobutyl ketone
Nitrobenzene
Organophosphorus cholin-
esterase inhibitors
Parathion
Pentachlorophenol
Perchloroethylene
Phenol
Styrene
Toluene
Trichloroethylene
Vanadium pentoxide
Xylenes
Acetone in urine
p-Aminophenol in urine
Methemoglobin in blood
Inorganic arsenic metabolites
in urine
Phenol in urine
Benzene in exhaled air
Cadmium in urine
Cadmium in blood
2-Thiothiazolidine-4-carboxylic
acid in urine
Carboxyhemoglobin in blood
Carbon monoxide in exhaled air
4-Chlorocathechol in urine
p-Chlorophenol in urine
Chromium in urine
Cobalt in urine
Cobalt in blood
N-Methylacetamide in urine
N-Methylformamide in urine
2-Ethoxyacetic acid in urine
Mandelic acid in urine
Ethyl benzene in exhaled air
Fluorides in urine
Furoic acid in urine
2,5-Hexanedione in urine
n-Hexane in exhaled air
Lead in blood
Inorganic mercury in urine
Inorganic mercury in blood
Methanol in urine
Methemoglobin in blood
Methyl chloroform in exhaled air
Trichloroacetic acid in urine
Trichloroethanol in urine
Trichloroethanol in blood
Methyl ethyl ketone in urine
Methyl isobutyl ketone in urine
p-Nitrophenol in urine
Methemoglobin in blood
Cholinesterase activity in red cells
p-Nitrophenol in urine
Cholinesterase activity in red cells
Pentachlorophenol in urine
Pentachlorophenol in plasma
Perchloroethylene in exhaled air
Perchloroethylene in blood
Trichloroacetic acid in urine
Phenol in urine
Mandelic acid in urine
Phenylglyoxylic acid in urine
Styrene in venous blood
Hippuric acid in urine
Toluene in venous blood
Toluene in exhaled air
Trichloroacetic acid in urine
Trichloroacetic acid and
trichloroethanol in urine
Freetrichloroethanol in blood
Trichloroethylene in blood
Trichloroethylene in exhaled air
Vanadium in urine
Methylhippuric acids in urine
100 mg/liter
50 mg/g creatinine
1.5%
50 pg/g creatinine
50 mg/g creatinine
0.12 ppm
5pg/g creatinine
5pg/liter
5 mg/g creatinine
3.5%
20 ppm
150 mg/g creatinine
25 mg/g creatinine
30pg/g creatinine
15pg/liter
1 pg/liter
30 mg/g creatinine
40 mg/g creatinine
100 mg/g creatinine
1.5g/g creatinine
10 mg/g creatinine
200 mg/g creatinine
5 mg/g creatinine
30pg/dl
35 pg/g creatinine
15pg/liter
15 mg/liter
1.5%
40 ppm
10 mg/liter
30 mg/liter
1 mg/liter
2 mg/liter
2 mg/liter
5 mg/g creatinine
1.5%
70% of
individual baseline
0.5 mg/g creatinine
70% of baseline
2 mg/g creatinine
5mg/liter
10 ppm
1 mg/liter
7 mg/liter
250 mg/g creatinine
300 mg/g creatinine
100 mg/g creatinine
0.02 mg/liter
2.5g/g creatinine
1 mg/liter
100 mg/g creatinine
300 mg/g creatinine
4 mg/liter
50pg/g creatinine
1.5g/g creatinine
1994
1991
1993
1987 Expected
1997
1988 1993
1988
1986 1993
1992
1990
1995
1995
1988
1994
1986
1990
1991
1987
1987
1993
1991
1990
1989
1996
1995
1995
1988
1993
1991
1989
1989
1988
1989
1987
1986
1986
1986
1996
1995
1986
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Figure 1. Interaction of factors leading from chemical exposure to disease, including the effects of susceptibility.
Adapted from Van Damme et al. (30). -, toxicokinetic ortoxicodynamic relationships; Tor.1, modifying effects.
substance or its metabolite in biological
media-and the biologically effective
dose-the concentration at the target
tissue or cells (31). Subsequent biological
processes lead to early biological effects
associated with the mechanism ofdisease
followed by changes in structure or func-
tion that can be detected clinically and are
predictors ofdisease, followed in turn by
clinical disease (11). Individual (host) fac-
tors modify the progression from each step
in the process to its successor and the collec-
tive influence ofthe host factors is termed
susceptibility. Variation in the host factors
is influenced by genetic determinants and
other environmental exposures.
Biological indicators, or biomarkers
(31), are often classified as addressing expo-
sure, effect, or susceptibility, based on this
general schematic. The application ofthe
BEI reference values has been limited to the
early stages in the process: internal dose,
biologically effective dose, and in a few
cases, early biological effect. The indicators
used in the BEI are therefore best consid-
ered biological indicators ofexposure, with
the acknowledgment that their level in an
individual reflects the influence ofsuscepti-
bility. In addition, since a fewofthe BEI are
consistent with monitoring early biological
effects, their application may be thought of
as biological monitoring ofresponse. Clear
distinctions between markers ofexposure
and those ofeffect remain elusive.
Use in PreventiveMeasures
Regardless ofthe term applied to biological
monitoring using the BEI as reference
values, its most important characteristic is
that this type ofmonitoring is part ofthe
strategy to prevent exposures that might
otherwise lead to occupational disease.
Conversely, the BEI are not appropriate for
use in identifying susceptible individuals or
in demonstrating the presence ofpreclinical
or clinical disease. Evaluating the latter
stages of the exposure-disease process is
certainly a legitimate application ofother
forms of biological monitoring such as
evaluation ofmutations, clastogenic effects,
or the presence ofdisease markers such as
P2-microglobulin; such later stage moni-
toring does not play a role in primary
prevention ofdisease (11,32).
Since the principal function ofindustrial
hygiene is the prevention or minimization
ofoccupational disease through control of
chemical exposures, the limitation used by
the ACGIH for its BEI is appropriate.
Further, biological monitoring ofexposure
using these reference values is complemen-
tary to ambient environmental monitoring
performed by industrial hygienists and other
occupational health specialists. The results
ofbiological monitoring will provide addi-
tional information regarding the conditions
ofoccupational exposure, which cannot be
obtained by sampling the air ofthe work-
place: the consequences ofskin absorption,
the effects ofphysical workload on chemical
uptake via inhalation, and the effectiveness
ofpersonal protective equipment in reduc-
ing worker exposure are three important
examples. It must also be emphasized that
biological monitoring cannot substitute for
air monitoring in the context ofexposure
prevention: a high biological result alone
will indicate possible excessive exposure but
will provide no information on the likely
source or mechanism of over-exposure.
Choosing an appropriate course ofaction
for control ofthe hazard requires informa-
tion beyond that obtained from biological
monitoring alone (7).
KeyCharacteristics Expected
ofBiomarkers ofExoure
Based on the premise that exposure preven-
tion will continue to be the major applica-
tion ofbiological monitoring and of the
BEI in industrial hygiene, the following
attributes can be identified as critically
important in the development ofnew meth-
ods and reference values. These characteris-
tics should be expected ofany biomarker
proposed for application to preventing
occupational exposure and disease.
Correlation with Exposure. The level
ofthe biological indicator must be related
clearly to the intensity and the duration of
exposure in humans (33). This relationship
must be demonstrable at levels ofexposure
found or expected in industrial settings.
The analytical limits ofquantitation ofthe
biological determinants must span the
range ofoccupational exposures.
Correlation with Target Tissue Dose.
Because the actual target tissue is seldom
accessible for sampling, surrogate fluids or
tissue must be used for biological monitor-
ing. The most common samples are peri-
pheral blood, voided urine, and exhaled
air. Depending on the target tissues, these
samples will reflect with variable accuracy
the biologically effective dose (33-36).
Reliable information on the relationship
between biological indicator level in
peripheral blood or urine and in the target
tissue is highlydesirable.
Appearance Is Reversible. The
reversibility ofthe biological indicator may
be most important in distinguishing indus-
trial hygiene applications from other uses
ofbiological monitoring (34,37,38). Since
the goal is prevention, the industrial hygien-
ist will be most interested in a biological
indicator that reveals the effectiveness of
control measures adopted after a judgment
ofhazardous exposure has been reached. If
the indicator is irreversible, its appearance
will alert the hygienist to a potentially haz-
ardous situation but will not provide evi-
dence that mitigating measures areworking.
Influence of Confounding and
ModifyingFactorsIs Well Characterized.
To interpret the results ofbiological moni-
toring correctly, the influence ofmodifying
and confounding factors must be under-
stood. These factors include the effect of
nonoccupational exposure to the agent of
interest, prior or simultaneous exposure to
other agents, host factors modifying the
response, and the general influence of
variation in environmental and individual
response (36).
SuitableforApplication in Working
Populations. Some types of biological
sampling are too invasive or risky for use in
the workplace and others may not be
acceptable to workers for a variety of rea-
sons. Adipose tissue, liver, or bone marrow
Environmental Health Perspectives * Vol 105, Supplement 1 * February 1997 1 10BIOLOGICAL EXPOSURE INDICES
sampling are examples ofthe former type.
In any successful application ofbiological
monitoring, the workers' cooperation must
be secured. For example, when samples
must be collected several hours after the end
ofa work shift to interpret the results prop-
erly (39), it is clear that the individuals must
take major responsibility for valid sampling.
Any procedure perceived by the workers to
be unpleasant or unnecessary likely will not
be followed (32,40).
Current Issues in Setting
and Revising Biological
Exposure Indices
A variety of stimuli and challenges will
arise in the course ofrevising the existing
BEI and developing new ones in the next
decade. These include scientific advances
in biological marker analysis and their rela-
tionships to disease and technical issues
related to the interpretation of measure-
ments in an individual worker. In addition,
there are some important nonscientific
impediments to the implementation of
biological monitoring that may slow the
process ofdeveloping reference values.
DevelopmentofNewMethods for
Markers ofEarlyBiologicalEffect
andSusceptibility
DNA andProteinAdducts. The ability to
determine the extent of reaction between
environmental chemical agents and biolog-
ical macromolecules such as DNA and pro-
teins is developing at a dramatic rate. The
appearance of DNA adducts in peripheral
blood lymphocytes and of hemoglobin
adducts in blood have been proposed as
markers of biologically effective dose or
early biological effect. A less-invasive
method based on collection ofbladder epi-
thelial cells in voided urine has also been
described (41). In some cases these adducts
can be shown to be specific to an environ-
mental agent orgroup ofagents, but in other
cases the adducts are not specific (37). In
addition, there remain questions about the
relationship ofadducts appearing in peri-
pheral blood to genetic damage presumed
to occurwithin the target cells (40,42).
ChromosomalAberrations, Sister
ChromatidExchange, andMicronuclei.
Structural changes in chromosomes and
other microscopic evidence ofdamage to
chromosomes, including the appearance
ofmicronuclei are also possible candidates
for occupational biological monitoring
methods. This form ofmonitoring is most
often classified as indicating altered struc-
ture or function and occasionally as an
indicator ofearly biological effect. In either
event, the reversibility ofthe marker is an
important characteristic that will influence
its role in the development of BEI values.
Insufficient data presently exist concerning
the sensitivity and specificity ofthese assays
at levels of exposure encountered in the
workplace (43).
Genetic Markers ofExposure and
Suseeptibility. Another developing area of
macromolecular biology is the analysis of
genetic material as an indicator of the
activity or inducibility of enzymes in an
individual (37). The variation in activity of
enzymes mediating phase I and phase II
metabolism of absorbed chemicals will
affect individual response to exposure in a
manner that can be predicted. Expression
ofenzyme activity is under genetic control,
as is the response of enzyme activity to
environmental exposures to the substrate
itself or to other chemicals (42). Charac-
terization of an individual's genotype can
provide markers of exposure to inducing
chemicals or markers ofsusceptibility to
later exposure.
NonscientificImpediments
toImplementation
The practice of biological monitoring in
U.S. industry has been limited by an array
ofsocial, political, and legal factors (44),
many ofwhich remain to be addressed.
Labor mistrust ofmanagement motives in
proposing biological monitoring is wide-
spread and is often predicated on the objec-
tions to invasion ofprivacy or suspicion that
the employer is actually seeking evidence
of drug abuse to use against employees.
Company managers have, in turn, objected
to proposals for biological monitoring on
the grounds that there is rarely a regulatory
mandate and that adverse findings might
leave the employer subject to legal action.
It has also been argued that the person-
alized results ofbiological monitoring could
provide an employer with the data to sup-
port discriminatory action against, for exam-
ple, employees demonstrating genetically
determined susceptibility to agents in the
workplace (45). Further, should a worker
be identified to be at elevated risk due to
personal biological factors such as heredi-
tary variation in metabolizing capability or
environmentally induced change in toxico-
kinetic processes, there is not commonly a
policy in place for fair treatment: financial
coverage for medical removal orjob transfer
is seldom planned for by the employer.
The principle ofconfidentiality ofmed-
ical records has at times interfered with the
use ofbiological monitoring data by indus-
trial hygienists. In keeping with the goal of
preventing or minimizing exposure, the
industrial hygienist must have access to
such data to conduct a complete exposure
assessment; at the same time, workers' rights
to confidentiality should be maintained and
the management scheme for accomplishing
these often contradictory goals must be
developed carefully in advance.
ScientificImpediments:
Variation andBackground
Several technical and scientific issues pose
obstacles to widespread use ofbiological
monitoring and BEI in industrial settings
where they could provide valuable infor-
mation (34). These include matters of
ambiguity in interpretation ofthe BEI and
the consequences ofthe general decline in
exposure levels in most industries with time.
Variability over time in biological levels
of an indicator within an individual and
between workers at the same time must arise
when the environmental concentrations
fluctuate. However, variation in toxicoki-
netics both within and between workers
also contributes and this component can
dominate the observed variability (46,47).
This poses substantial difficulty in inter-
preting a single biological monitoring
result by comparison to the BEI: if the
result exceeds the BEI, is this evidence for a
hazardous exposure? The BEI Committee
has taken a general approach to this issue
by advising that due to biological variability
it is possible for an individual's measure-
ment to exceed the BEI without incurring
an increased health risk. If, however, mea-
surements in specimens obtained from a
worker on different occasions persistently
exceed the BEI or ifthe majority ofwork-
ers at the same workplace exceed the BEI,
the cause of the excessive values must be
investigated and control measures must be
implemented. This suggests that in some
instances the group mean rather than the
individual values should be compared to
the BEI and that serial measurements may
be necessary. Present data concerning indi-
vidual variability are not sufficient to place
more precise limits on the acceptable range
ofvalues about the BEI. However, some
techniques have been described recently for
predicting the expected distribution ofbio-
logical levels among normal workers with
realistic variation in toxicokinetic parame-
ters (48,49). As these techniques become
refined, it should be possible to specify the
BEI as a reference distribution (37,50)
rather than a single value, permitting
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estimation of the probability ofa worker
showing an observed biological level when
exposed at or below the TLV. Using this
approach, the development ofconfidence
or tolerance intervals for workers or groups
ofworkers should enhance the utility of
biological monitoring ofexposure and of
the BEI recommendations.
In many western nations, particularly in
the larger industrial facilities, there has been
a steady decline in exposure levels over time
owing to developments in both industrial
technology and hygienic practices. A signifi-
cant consequence is that biological levels
in workers in these industries have also
declined and in some instances are now
comparable to background levels found in
persons without occupational exposure
(32). Many industries using lead and
toluene are examples. Further, the lowering
ofacceptable air concentrations, driven in
part by revisions in theTLV, also contribute
to this trend. Ifreference values for biologi-
cal monitoring are revised downward in
concert with TLV, they will overlap back-
ground levels with increasing frequency.
Fluctuation in background may then cause
individual measurements in workers to
appear to exceed the BEI, leading to a con-
clusion that a hazardous situation exists. If
the BEI is based on a direct relation to
health effect (as is now the case for only a
few substances), then this condusion would
be correct, even though the major source of
exposure to the hazard is now outside the
workplace. However, ifthe BEI is based on
a corresponding dose from inhalation at the
TLV, the assessment is ambiguous. Ifexpo-
sure by other routes is possible, simultane-
ous measurement ofair concentration in the
workplace will not resolve the problem
completely. Clarification ofthis ambiguity
in interpretation remains one ofthe respon-
sibilities ofthe committees charged with set-
ting the TLV and BEI. For example, rather
than including background, the BEI might
be described as representing the increment
above background in biological level ofa
marker that would be expected to result
from inhalation exposure at the TLV. This
subtle but important change has been sug-
gested, but its implications have not been
thoroughly examined.
Prospectsforthe
Next Decade
Legal and d ulatryEnvironment
The regulatory status ofbiological monitor-
ing in the United States is rather limited;
only for lead and cadmium do federal
occupational safety and health regulations
require employers to provide biological
monitoring ofworkers. In addition, it is
not clear that the government has the
authority to require workers to submit to
biological monitoring (45). Because ofthe
slow process involved in setting or revising
these regulations and the impediments
mentioned above, this situation does not
appear likely to change in the near future.
Manyemployers, most ofthem large corpo-
rations, have voluntarily implemented bio-
logical monitoring programs for substances
such as fluorides, mercury, and cobalt, but
a systematic evaluation ofthe prevalence of
biological monitoring programs in the
United States has not been reported.
One important feature ofthis unsettled
regulatory picture is the balance ofcost ver-
sus benefit for biological monitoring. This
type ofsampling is more labor intensive
than air sampling and often requires the
participation ofqualified health care spe-
cialists. In addition, the chemical analysis of
biological matrices is technically more diffi-
cult than that ofair samples. As a result,
the cost ofbiological monitoring per sam-
ple taken is substantially higher than that
for air sampling. It has been suggested that
the benefits ofbiological monitoring sel-
dom outweigh the costs, particularly when
the possibility oflegal action arises over
high values or when medical removal and
employee compensation must be provided.
Others have argued that if a complete
accounting ofall costs and benefits associ-
ated with preventing work-related disease
and compensation is done, biological mon-
itoringwill prove to be economical (45).
ScientificDevelopments
GeneticAnalysisforEvidence ofExposure
orSusceptibility. Methods for determining
the genotype of individual workers are
developing very rapidly. One ofthe most
interesting approaches is the measurement
ofenzyme-specific mRNA as an indicator
of exposure to a substance capable of
inducing the enzyme. Methods employing
reverse transcription combined with poly-
merase chain reaction amplification may
have sufficient sensitivity and specificity to
detect exposure to carcinogenic agents or
cigarette smoke at low levels (51). Studies
ofthe expression of mRNA in chemically
exposed populations are in progress and may
lead to a powerful method for individual
biological monitoringofexposure.
One ofthe major factors determining
individual differences in susceptibility to
chemical exposure is variation in metabolic
handling ofsolvents and other agents (33).
The existence ofgenetically determined
bimodal or multimodal distributions of
metabolizing capability in humans has been
known for some time (52). For example,
the ability to oxidize debrisoquine, medi-
ated by one ofthe cytochrome P450 isoen-
zymes, shows a bimodal distribution in the
Caucasian population and this genetic
dimorphism is associated with similar dif-
ferences in rates ofmetabolism ofcertain
industrial chemicals (53). There is a similar
genetic polymorphism in the rate ofconju-
gation ofmetabolites mediated by N-acetyl-
transferase (42). The ability to classify
workers based on their genotypes into sus-
ceptible subgroups is nearly at hands and
could have important applications in
preventingwork-related disease.
Advance ofAnalyticalSensitivity and
Specificity. Steady improvement in the
limit ofdetection, sensitivity, and specificity
ofanalytical chemical methods supports
theviewthatbiological monitoringmethods
will continue to advance. Determination of
macromolecular reaction products that are
specific to the industrial chemical agent
will be ofspecial interest. Advances in ana-
lytical performance must be accompanied
by quality control procedures (37) and
by continuing careful assessment of all
sources ofvariation in observed levels of
the biological determinant.
Better Sampling Techniques. The lack
ofstrong correlation between some biologi-
cal indicators ofexposure and the biologi-
cally effective dose at the target tissue
remains a significant concern. One poten-
tially useful approach to this problem is the
use ofmethods to determine the level ofa
chemical agent or its metabolite in situ
without withdrawing a tissue sample (33).
Two techniques have been described for
accomplishing this: neutron activation
analysis for determination ofcadmium in
kidney and liver tissue, of mercury in
brain, kidney, and liver tissue, and ofsili-
con in the lungs as a marker ofcrystalline
silica exposure; and X-ray fluorescence
analysis oflead in teeth and bone, ofcad-
mium in kidney and liver, and ofmercury
in the kidney (54). Both methods are tech-
nically complex, requiring the use ofcostly
instruments, and they also involve absorp-
tion ofdoses ofionizing radiation that are
significant relative to background expo-
sures in the general population. The ability
to locate the contaminant within a selected
target organ is the principal advantage of
these techniques. Their application may be
limited to situations inwhich the long-term
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accumulation of toxicant or metabolite
must be evaluated to assess risk.
Additional research is also needed to
develop and improve less invasive methods
ofsampling fluids or tissues for biological
monitoring. Sampling ofhair, fingernails,
and sweat have been explored and largely
dismissed owing to problems ofcontamina-
tion from sources external to the circula-
tion. Exhaled breath and saliva remain
promising fluids whose collection poses
considerably fewer problems than that of
blood or urine. However, breath sampling
is still hampered by analytical limitations
imposed by the high concentrations of
water vapor and carbon dioxide (55) and
by the relatively low concentrations of
volatile agents after typical occupational
exposures. Improvements in analytical
methods should support wider application
of breath sampling. Saliva sampling has
been proposed recently as a practical
method for monitoring occupational expo-
sure, based on data from experimental ani-
mals showing a strong correlation between
plasma levels ofselected pesticides and their
concentration in saliva (56) and on a
reported method for determining cadmium
in saliva (57).
Better Data on Toxicokineties and
Overall Pathophysiology. While each of
the above developments is cause for excite-
ment and optimism, none will find wide
application in occupational biological mon-
itoring until considerable data are collected
on the toxicokinetics and overall patho-
physiology ofthe markers and their associ-
ated exposure or effects. There remains a
serious shortage ofdata from both experi-
mentally controlled exposures and epidemi-
ologic investigations that are essential to
support the adoption ofa biological moni-
toring method and, in particular, ofa refer-
ence value. There are some obstacles to
expansion of these research activities,
including ethical concerns over controlled
experimental exposures ofhuman volun-
teers to potentially toxic agents. Greatly
improved analytical sensitivity and speci-
ficity for chemicals or metabolites in tissues
may permit use of controlled doses in
humans that are at or below those occurring
in current occupational settings (58). That
trend could relieve some of the concern
over the risk and benefit balance for clinical
experimentation in this area.
For biological markers ofearly response
and susceptibility, an additional ethical
concern has been articulated (59). For
example, ifin an epidemiological study ofa
biomarker ofeffect aimed at determining
its prevalence and reliability as a function of
exposure, early on its prevalence is elevated
in certain workers, it may be very difficult
to complete the study: the employer may
wish to modify the working conditions to
lower exposures on the basis ofearly appear-
ance ofa biomarker that could be associ-
ated with health risk. While this decision
would be fully defensible in view of the
desire to prevent adverse health outcomes,
it could be devastating to the research
design. Epidemiologists pursuing data that
are essential to the validation ofbiological
markers in exposed working populations
must be prepared to deal with this problem.
Access to worker populations for epi-
demiologic research is also constrained to
some extent by the need to plan for possi-
ble compensation costs should workers in
the study reveal evidence ofearly biological
effects. Many employers are unwilling to
permit such investigations in their facilities
on the grounds that the risk ofsubsequent
litigation and compensation cannot be
undertaken. In may be necessary to include
thorough discussion ofhow various out-
comes will be managed, with respect to
communicatingwithworkers and to provid-
ing for adverse results whether perceived or
real, in the planning of epidemiologic
investigations (45,60).
Intelnational Cooperation
Other nations and organizations have
developed reference values for biological
monitoring. The most extensive are the
Biological Tolerance Values (BAT) ofthe
German Research Society (38,40); refer-
ence values and methods have also been
developed in the United Kingdom, in
Japan, and by nations of the European
Community (6,7,61). In many cases the
reference values are similar, but there are
significant differences in both the approach
to setting biological reference values and in
their interpretation (38). For example, the
BAT are established as maximum tolerable
levels (40); inJapan, thevalues are specified
according to a reference distribution with
three levels (62); whereas in the United
States, the ACGIH values are generally
linked to air concentrations and apply to
nearly all workers. The different approaches
are the principal explanation for differences
in the specific reference values; geographic
variation in background levels may also
influence the reference levels (50). There is
considerable interest among many organiza-
tions in developing more uniform interna-
tional criteria for biological reference values
(63). Such international harmonization of
criteria could be beneficial to employers,
workers, and scientists.
Summary
The BEI established by ACGIH can play a
significant role in the evaluation and con-
trol ofexposure to hazardous chemicals in
the workplace. These reference values have
been developed bya small committee ofsci-
entists and occupational health profession-
als as suggested guidelines for judgment of
the acceptability ofbiological monitoring
results in exposed worker populations. At
present the BEI specify the level ofindus-
trial chemical, metabolite(s) or biochemical
change related to exposure and most indices
are linked to the corresponding TLV. New
BEI and revision ofexisting reference values
will take into account scientific advances in
toxicokinetic and toxicodynamic under-
standing, as well as new developments
derived from research in macromolecular
biology, including genetic markers ofsus-
ceptibility and early biological effect.
However, the underlying requirements for
application of biological monitoring of
exposure will continue to dominate deci-
sions for new BEI in the next decade; the
biological indicators must be correlated
with exposure and with levels at the target
tissue, theymust be reversible, they must be
well characterized with respect to the influ-
ence ofmodifying and confounding vari-
ables, and they must be suitable for practical
application in working populations. Several
impediments to wider application ofbiolog-
ical monitoring ofexposure, susceptibility,
and early effect maybe overcome in the near
future, leading to more effective prevention
ofoccupational illness anddisability.
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